High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$23.1M
$23,060,024
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -32.5%
|
2026-02-26 | $378,266x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -45.2%
|
2026-02-25 | $364,041 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-24 | $361,630x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-20 | $361,967x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -19.2%
|
2026-02-19 | $353,808 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-18 | $361,825x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -13.9%
|
2026-02-13 | $365,822 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-11 | $732,186x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-10 | $3,005,525Largex2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-05 | $5,362,103Whalex6 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-02-04 | $144,863 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -11.8%
|
2026-02-03 | $400,610x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -17.3%
|
2026-01-30 | $268,350 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -14.9%
|
2026-01-29 | $271,687 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-23 | $50,084 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-22 | $552,420x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -33.0%
|
2026-01-21 | $612,128 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-15 | $117,348 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-14 | $147,983x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -19.5%
|
2026-01-13 | $304,422 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-09 | $8,554 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2026-01-07 | $13,149 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-12-11 | $235,405x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-12-04 | $145,096x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-12-03 | $143,511 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -11.6%
|
2025-12-01 | $146,636 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -10.4%
|
2025-11-28 | $149,740 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -13.5%
|
2025-11-26 | $232,434 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -15.2%
|
2025-11-25 | $309,240 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-20 | $147,002x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-18 | $231,377x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-17 | $235,254 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -24.0%
|
2025-11-13 | $391,417x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-11-12 | $973,976 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-10 | $1,734,767Largex4 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-07 | $150,851 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-05 | $145,075x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-11-04 | $151,703x2 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-30 | $144,582 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-29 | $146,627 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-28 | $146,277 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-24 | $146,956 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-23 | $141,432 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -16.1%
|
2025-10-22 | $477,552 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -40.2%
|
2025-10-20 | $649,176 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 Sell
|
2025-10-17 | $28,022 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -33.7%
|
2025-09-30 | $834,412 | S | Form 4 |
| PAHC |
PHIBRO ANIMAL HEALTH CORP
|
CEO
10b5-1 SellΔOwn -18.3%
|
2025-09-18 | $282,732 | S | Form 4 |